Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
8.01
-0.11 (-1.35%)
At close: Mar 28, 2025, 4:00 PM
8.13
+0.12 (1.50%)
After-hours: Mar 28, 2025, 7:56 PM EDT
Avadel Pharmaceuticals Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Avadel Pharmaceuticals stock have an average target of 18.86, with a low estimate of 12 and a high estimate of 30. The average target predicts an increase of 135.46% from the current stock price of 8.01.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Avadel Pharmaceuticals stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +137.20% | Mar 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +162.17% | Mar 4, 2025 |
| Needham | Needham | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +137.20% | Mar 3, 2025 |
| Deutsche Bank | Deutsche Bank | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +49.81% | Feb 11, 2025 |
| UBS | UBS | Strong Buy Maintains $22 → $14 | Strong Buy | Maintains | $22 → $14 | +74.78% | Jan 13, 2025 |
Financial Forecast
Revenue This Year
254.99M
from 169.12M
Increased by 50.78%
Revenue Next Year
337.71M
from 254.99M
Increased by 32.44%
EPS This Year
0.08
from -0.51
EPS Next Year
0.70
from 0.08
Increased by 761.15%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 267.5M | 386.9M | 463.3M | ||
| Avg | 255.0M | 337.7M | 407.8M | ||
| Low | 235.7M | 270.7M | 318.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 58.1% | 51.7% | 37.2% | ||
| Avg | 50.8% | 32.4% | 20.7% | ||
| Low | 39.4% | 6.2% | -5.8% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 0.19 | 1.06 |
| Avg | 0.08 | 0.70 |
| Low | -0.04 | 0.14 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | 1,213.9% |
| Avg | - | 761.2% |
| Low | - | 70.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.